id: diabetes_diagnosis_to_NEW:hexose_sum_elevation
name: Diabetes Diagnosis â†’ Hexose Sum Elevation
from_node:
  node_id: diabetes_diagnosis
  node_name: Diabetes Diagnosis
to_node:
  node_id: NEW:hexose_sum_elevation
  node_name: Hexose Sum Elevation
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Type 2 diabetes causes persistent hyperglycemia and dysregulated glucose homeostasis'
- 'Step 2: Elevated blood glucose increases circulating hexose (glucose and related sugars) concentrations'
- 'Step 3: Mendelian randomization confirms reverse causation: diabetes causes hexose elevation, not vice
  versa'
- 'Step 4: Sum of hexoses serves as a biomarker consequence rather than cause of diabetes'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Sapna Sharma et al. 2024. "Role of human plasma metabolites in prediabetes and type
    2 diabetes from the IMI-DIRECT study.." https://doi.org/10.1007/s00125-024-06282-6
  supporting_citations:
  - Two-sample Mendelian randomization methodology studies
  - Glycemic biomarker studies
  - Additional citations require full-text access
  doi: 10.1007/s00125-024-06282-6
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Causal inference using genetic variants demonstrates that the sum of hexoses is causally
  downstream of type 2 diabetes (type 2 diabetes-to-metabolite direction), distinguishing this from metabolites
  that causally contribute to diabetes development.
quantitative_effects:
  sample_size: 3000
structural_competency:
  equity_implications: Understanding causal direction is critical for intervention design. This finding
    suggests hexose elevation is a consequence of diabetes rather than a modifiable upstream cause, redirecting
    intervention focus to upstream structural factors affecting lipid and BCAA metabolism.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.681114'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
